Finance

Beta
Lists
6826:HKG
Shanghai Haohai Biological Technology
HK$18.50
+1.48%
(+0.27) 1D
Jun 1, 4:08:26 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6826...
Open
HK$18.20
High
HK$18.59
Low
HK$18.20
Mkt. cap
8.51B
Avg. vol.
179.65K
Volume
248.80K
Dividend
6.16%
Quarterly dividend
HK$0.28
Ex-dividend date
Jun 4, 2026
P/E ratio
14.79
52-wk high
HK$31.28
52-wk low
HK$18.00
EPS
HK$1.25
Shares outstanding
40.05M
No. of employees
2K
Open
HK$18.20
High
HK$18.59
Low
HK$18.20
Mkt. cap
8.51B
Avg. vol.
179.65K
Volume
248.80K
Dividend
6.16%
Quarterly dividend
HK$0.28
Ex-dividend date
Jun 4, 2026
P/E ratio
14.79
52-wk high
HK$31.28
52-wk low
HK$18.00
EPS
HK$1.25
Shares outstanding
40.05M
No. of employees
2K
News stories
From sources across the web
An error has occurred
About Shanghai Haohai Biological Technology
CEO-
Employees2.11K
FoundedJan 24, 2007
Headquarters-
SectorBiotechnology
Website3healthcare.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
674.09M
606.45M
547.22M
571.44M
Cost of goods sold
197.84M
176.00M
194.43M
192.47M
Cost of revenue
197.84M
176.00M
194.43M
192.47M
Research and development expenses
49.98M
50.70M
48.68M
51.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
316.45M
325.53M
323.79M
247.28M
Operating expense
366.48M
343.99M
407.16M
304.13M
Total operating expenses
564.32M
519.99M
601.59M
496.60M
Operating income
109.78M
86.46M
-54.37M
74.84M
Other non operating income
-3.05M
6.89M
107.28M
-3.32M
EBT including unusual items
132.30M
109.87M
-106.26M
96.26M
EBT excluding unusual items
127.60M
104.81M
67.47M
80.49M
Income tax expense
14.45M
17.07M
-20.11M
24.60M
Effective tax rate
10.92%
15.53%
18.92%
25.56%
Other operating expenses
22.61K
-33.43M
35.89M
4.04M
Net income
120.75M
93.58M
-53.64M
73.56M
Net profit margin
17.91%
15.43%
-9.80%
12.87%
Earnings per share
-
-
-
-
Interest and investment income
19.45M
18.73M
25.05M
11.27M
Interest expense
-3.18M
-2.67M
-10.50M
-2.30M
Net interest expenses
16.27M
16.06M
14.54M
8.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
154.86M
130.72M
-9.64M
119.57M
Gain or loss from assets sale
-
-
201.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer